Preoperative radiotherapy with capecitabine and mitomycin C in locally advanced rectal carcinoma

Cancer Chemotherapy and Pharmacology

Volumn 68, Issue 3, 2011, Pages 787-793

  Stojanovic, Suzana ^a   Popov, Ivan ^a   Radosevic Jelic, Ljiljana ^a   Micev, Marjan ^b   Borojevic, Nenad ^a   Nikolic, Vladimir ^a   Krivokapic, Zoran ^b   Kecmanovic, Dragutin ^b   Gavrilovic, Dusica ^a   Kezic, Iva ^a  

^a INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

^b University Clinical Center   (Serbia)

Author keywords

Capecitabine; Locally advanced disease; Mitomycin C; Radiotherapy; Rectal cancer

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C;

ADULT; ADVANCED CANCER; AGED; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GRANULOCYTOPENIA; HAND FOOT SYNDROME; HISTOPATHOLOGY; HUMAN; LINEAR ACCELERATOR; LYMPH NODE; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROTOXICITY; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DERMATITIS; RADIATION DOSE; RECTUM CARCINOMA; SIDE EFFECT; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT DURATION; TREATMENT RESPONSE; VEIN THROMBOSIS; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL; TREATMENT OUTCOME;

EID: 80054693489     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-010-1469-8     Document Type: Article

References (23)

1. V Valentini B Glimelius B Minsky E Van Cutsem H Bartelink RG Beets-Tan JP Gerard P Kosmidis L Pahlman A Picciocchi P Quirke J Tepper M Tonato CJ Van de Velde N Cellini P Latini 2005 The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for an European Consensus Radiother Oncol 76 241 250 16165238 10.1016/j.radonc.2005.07.001
2. K Bujko MP Nowacki 2002 Emerging standards of radiotherapy combined with radical rectal cancer surgery Cancer Treat Rev 28 101 103 12297118 10.1053/ctrv.2002.9259 1:STN:280:DC%2BD38vos1GisA%3D%3D
3. JF Bosset G Calais A Daban C Berger LJ Radošević- Jelić P Maingon E Bardet M Pierart A Briffaux EORTC Radiotherapy Group 2004 Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute-toxicity and treatment compliance. Report of the 22921 randomized trial conducted by the EORTC Radiotherapy Group Eur J Cancer 40 219 224 14728936 10.1016/j.ejca.2003.09.032 1:STN:280: DC%2BD2c%2FivFentg%3D%3D
4. JP Gérard T Conroy F Bonnetain O Bouché O Chapet MT Closon-Dejardin M Untereiner B Leduc E Francois J Maurel JF Seitz B Buecher R Mackiewicz M Ducreux L Bedenne 2006 Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203 J Clin Oncol 24 4620 4625 17008704 10.1200/JCO.2006.06.7629
5. YT Seiwert JK Salama EV Everett 2007 The concurrent chemoradiation paradigm-general principles Nat Clin Pract Oncol 4 86 100 17259930 10.1038/ncponc0714 1:CAS:528:DC%2BD2sXitlWqu78%3D
6. C Blanquicett GY Gillespie LB Nabors CR Miller S Bharara DJ Buchsbaum RB Diasio MR Johnson 2002 Induction of thymidine phosphorylase in both irradiated and shielded, contralateral human U87MG glioma xenografts: implications for a dual modality treatment using capecitabine and irradiation Mol Cancer Ther 1 1139 1145 12481438 1:CAS:528:DC%2BD3sXmtFamtA%3D%3D
7. N Sawada T Ishikawa F Sekiguchi Y Tanaka H Ishitsuka 1999 X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts Clin Cancer Res 5 2948 2953 10537364 1:CAS:528:DyaK1MXntlGlu74%3D
8. Colvin OM, Friedman HS (2005) Alkylating agents-mitomycin C. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer principles and practice of oncology, 7th edn. Lippincot Williams and Wilkins, Philadelphia, pp 332-344
9. Y Ogata K Matono T Sasatomi N Ishibashi S Torigoe T Fukumitsu T Mizobe N Yamashita T Yanagawa K Shirouzu 2006 Upregulation of thymidine phosphorylase in rectal cancer tissues by mitomycin C J Surg Oncol 93 47 55 16353181 10.1002/jso.20390 1:CAS:528:DC%2BD28XotlOqug%3D%3D
10. ICRU Report 50 (1993) Prescribing, recording and reporting photon beam therapy. International Commission on Radiation Units and Measurements, Washington
11. P Therasse SG Arbuck EA Eisenhauer J Wanders RS Kaplan L Rubinstein J Verweij M Van Glabbeke AT van Oosterom MC Christian SG Gwyther 2000 New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 205 216 10655437 10.1093/jnci/92.3.205 1:STN:280:DC%2BD3c7it1Gitg%3D%3D
12. NCI-Common Toxicity Criteria (1999) Version 2.0. National Cancer Institute, Division of Cancer Treatment
13. O Dworak L Keilholz A Hoffmann 1997 Pathological features of rectal cancer after preoperative radiochemotherapy Int J Colorectal Dis 12 19 23 9112145 10.1007/s003840050072 1:STN:280:DyaK2s3ms1emsw%3D%3D
14. PJ Medina JM Sipols JN George 2001 Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome Curr Opin Hematol 8 286 293 11604563 10.1097/00062752-200109000-00004 1:STN:280:DC%2BD3Mrls1Gksw%3D%3D
15. V Valentini C Coco A Picciocchi A Morganti L Trodella A Ciabattoni F Cellini B Barbaro S Cogliandolo G Nuzzo GB Doglietto F Ambesi-Impiombato M Cosimelli 2002 Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients Int J Radiat Oncol Biol Phys 53 664 674 12062610 10.1016/S0360-3016(02)02764-5
16. I Chau M Allen D Cunningham D Tait G Brown M Hill K Sumpter A Rhodes A Wotherspoon AR Norman A Hill A Massey Y Prior 2003 Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer Br J Cancer 88 1017 1024 12671697 10.1038/sj.bjc.6600822 1:CAS:528:DC%2BD3sXisFahtro%3D
17. E Van Cutsem C Twelves J Cassidy D Allman E Bajetta M Boyer R Bugat M Findlay S Frings M Jahn J McKendrick B Osterwalder G Perez-Manga R Rosso P Rougier WH Schmiegel JF Seitz P Thompson JM Vieitez C Weitzel P Harper Xeloda Colorectal Cancer Study Group 2001 Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study J Clin Oncol 19 4097 4106 11689577
18. PM Hoff R Ansari G Batist J Cox W Kocha M Kuperminc J Maroun D Walde C Weaver E Harrison HU Burger B Osterwalder AO Wong R Wong 2001 Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study J Clin Oncol 19 2282 2292 11304782 1:CAS:528:DC%2BD3MXjsFeqsrw%3D
19. C Twelves A Wong MP Nowacki M Abt H Burris 3rd A Carrato J Cassidy A Cervantes J Fagerberg V Georgoulias F Husseini D Jodrell P Koralewski H Kröning J Maroun N Marschner J McKendrick M Pawlicki R Rosso J Schüller JF Seitz B Stabuc J Tujakowski G Van Hazel J Zaluski W Scheithauer 2005 Capecitabine as adjuvant treatment for stage III colon cancer N Engl J Med 352 2696 2704 15987918 10.1056/NEJMoa043116 1:CAS:528:DC%2BD2MXls1SktL0%3D
20. C Twelves M Boyer M Findlay J Cassidy C Weitzel C Barker B Osterwalder C Jamieson K Hieke Xeloda Colorectal Cancer Study Group 2001 Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma Eur J Cancer 37 597 604 11290435 10.1016/S0959-8049(00)00444-5 1:CAS:528: DC%2BD3MXisVSqt78%3D
21. Hofheinz R, Wenz F, Post S, Matzdorff A, Laechelt S, Mueller L, Link H, Moehler M, Burkholder I, Hochhaus A (2009) Capecitabine (Cape) versus 5-fluorouracil (5-FU)-based (neo-)adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): safety results of a randomized, phase III trial. J Clin Oncol 27:15s (suppl; abstr 4014)
22. R Glynne-Jones H Meadows S Wan S Gollins M Leslie E Levine AC McDonald S Myint L Samuel D Sebag-Montefiore National Cancer Research Institute Anal Sub Group and Colorectal Clinical Oncology Group 2008 EXTRA-a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer Int J Radiat Oncol Biol Phys 72 119 126 18472366 10.1016/j.ijrobp.2007.12.012 1:CAS:528:DC%2BD1cXhtVamu77E
23. R Glynne-Jones J Dunst D Sebag-Montefiore 2006 The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been? Ann Oncol 17 361 371 16500912 10.1093/annonc/mdj052 1:STN:280:DC%2BD287ht1OrtQ%3D%3D